1 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
2 Department of Neurology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Otolaryngol Head Neck Surg. 2018 Mar;158(3):505-510. doi: 10.1177/0194599817741839. Epub 2017 Nov 21.
Objective Neurofibromatosis 2 (NF2) is a neuro-oncologic condition that presents with bilateral vestibular schwannomas of the cerebellopontine angle (CPA). Voice and swallowing impairment can occur from direct involvement or compression of the vagus nerve or as the result of surgical excision of CPA tumors. The objectives in this study are to (1) assess the prevalence of voice and swallowing impairments and (2) analyze the effects of vagal dysfunction in patients with NF2. Study Design Cross-sectional. Setting Academic tertiary care center. Subjects and Methods Patients at a neurofibromatosis center were mailed Voice Handicap Index and Sydney Swallow Questionnaire surveys. Stroboscopic, voice, and swallowing evaluations were performed for patients who elected to participate in screening exams. Results There were high rates of self-assessed and objective voice and swallowing handicaps in this population. Fourteen of 40 (35%) patients had a self-assessed voice handicap, and 20 of 40 (50%) patients had a self-assessed swallow handicap. Vocal fold motion impairment (VFMI) was observed in 22 of 31 (71%) patients examined, with 27 of 62 (44%) possible vocal cords affected. Velopharyngeal insufficiency (45%) and piriform sinus pooling or residue (39%) were seen in a significant percentage of patients. There was a significant relationship between vocal cord motion impairment and CPA surgical intervention ipsilateral to the impairment ( P = .002). The presence of VFMI was strongly associated with voice ( P = .002) and swallowing ( P = .01) impact on quality of life. Conclusion Speech and swallowing impairments are highly prevalent in patients with NF2, cause significant impact on quality of life, and are most commonly related to surgical interventions in the CPA region.
目的 神经纤维瘤病 2 型(NF2)是一种神经肿瘤疾病,表现为桥小脑角(CPA)的双侧前庭神经鞘瘤。由于迷走神经的直接受累或压迫,或由于 CPA 肿瘤的手术切除,可发生声音和吞咽障碍。本研究的目的是:(1)评估声音和吞咽障碍的发生率;(2)分析 NF2 患者迷走神经功能障碍的影响。 研究设计 横断面研究。 地点 学术三级保健中心。 研究对象和方法 神经纤维瘤病中心的患者邮寄了嗓音障碍指数和悉尼吞咽问卷调查。选择参加筛查检查的患者进行频闪喉镜、嗓音和吞咽评估。 结果 该人群自我评估和客观声音和吞咽障碍的发生率很高。40 名患者中有 14 名(35%)自我评估有嗓音障碍,40 名患者中有 20 名(50%)自我评估有吞咽障碍。在接受检查的 31 名患者中,有 22 名(71%)存在声带运动障碍(VFM),62 名中有 27 名(44%)可能存在声带异常。相当一部分患者存在软腭功能不全(45%)和梨状隐窝积液或残留(39%)。声带运动障碍与同侧 CPA 手术干预之间存在显著关系(P =.002)。VFM 存在与嗓音(P =.002)和吞咽(P =.01)对生活质量的影响有显著关系。 结论 NF2 患者的言语和吞咽障碍发生率较高,对生活质量有显著影响,且最常与 CPA 区域的手术干预有关。